Bowman Hit With Two Merger Suits; Adds Proxy Disclosures Ahead of Nov 4 Vote
BWMN sits 71% above its 52-week low of $25.07 on light trading volume (0.2× avg).
Summary
Bowman faces two stockholder lawsuits seeking to enjoin its $43.00-per-share sale to Bernhard Capital Partners and has voluntarily added valuation and litigation disclosures to its proxy ahead of the November 4, 2026 special meeting.
Key Events · M&A and Partnerships · BWMN
-
Two Merger Suits Filed
Smith v. Bowman Consulting Group Ltd. was filed October 14, 2026 and Scott v. Bowman Consulting Group Ltd. on October 15, 2026 in New York Supreme Court, naming the company and every board member and seeking to enjoin the merger absent additional disclosures, or rescission and damages.
-
Demand Letters Allege Proxy Deficiencies
Several purported stockholders sent demand letters claiming the September 25, 2026 preliminary proxy or the definitive proxy contained materially misleading and incomplete statements about the merger.
-
Voluntary Proxy Supplement Filed
Without admitting liability, Bowman supplemented the proxy with BofA's selected-transaction multiples (13.5x mean and median EV/EBITDA; 10.5x-13.5x applied to $79 million of trailing-twelve-month Adjusted EBITDA) and DCF inputs of 10.0%-12.0% discount rates on roughly 17.666-17.848 million fully diluted shares.
-
Analyst Target Range Disclosed
The supplement adds publicly available one-year forward analyst price targets as of August 7, 2026 of $38.00 to $58.00, discounted at a 13% cost of equity to $33.63-$51.33 per share.
Analysis · BWMN · Trade & Services
Two stockholder suits filed October 14-15 in New York Supreme Court seek to block the $43.00-per-share all-cash sale to Bernhard Capital Partners unless Bowman discloses more, and the company responded by voluntarily supplementing its proxy rather than admitting fault. The added material is substantive: BofA's comparable-transaction work now shows a 13.5x mean and median EV/EBITDA and a 10.5x-13.5x applied range on $79 million of Adjusted EBITDA, plus a DCF using 10.0%-12.0% discount rates and roughly 17.7-17.8 million fully diluted shares. With the special meeting set for November 4, 2026, the practical risk is a disclosure-based injunction that delays the closing; the company says the claims are without merit and that no supplemental disclosure was legally required.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 30.7% of the 1698 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BWMN was trading at $42.87 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $743M. The 52-week trading range was $25.07 to $45.83. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.